Document Detail

Impact of Statin Therapy on Late Target Lesion Revascularization After Sirolimus-Eluting Stent Implantation (from the CREDO-Kyoto Registry Cohort-2).
MedLine Citation:
PMID:  22381164     Owner:  NLM     Status:  Publisher    
Therapeutic strategies preventing late target lesion revascularization (TLR) after drug-eluting stent implantation have not been yet adequately investigated. In 13,087 consecutive patients undergoing first percutaneous coronary intervention in the CREDO-Kyoto Registry Cohort-2, we identified 10,221 patients who were discharged alive after implantation of sirolimus-eluting stents (SESs) only (SES stratum 5,029) or bare-metal stents (BMSs) only (BMS stratum 5,192). Impact of statin therapy at time of discharge from the index hospitalization on early (within the first year) and late (1 year to 4 years) TLR, was assessed in the SES stratum (statin group 2,735; nonstatin group 2,294) and in the BMS stratum (statin group 2,576; nonstatin group 2,616). Despite a significantly lower incidence of early TLR (7.8% vs 22.2%, p <0.0001), SES use compared to BMS use was associated with a significantly higher incidence of late TLR (7.7% vs 3.0%, p <0.0001). In the SES and BMS strata, the incidence of early TLR was similar regardless of statin use. In the SES stratum, the incidence of late TLR was significantly lower in the statin group than in the nonstatin group (6.1% vs 9.6%, p = 0.002), whereas no significant difference was found in the BMS stratum (2.6% vs 3.3%, p = 0.38). After adjusting confounders, risk for late TLR significantly favored statin use in the SES stratum (hazard ratio 0.73, 95% confidence interval 0.54 to 0.98, p = 0.04), whereas the risk decrease was not significant in the BMS stratum (hazard ratio 0.74, 95% confidence interval 0.46 to 1.20, p = 0.23). In conclusion, statin therapy at hospital discharge was associated with a significantly lower risk for late TLR after SES implantation.
Masahiro Natsuaki; Yoshihisa Nakagawa; Takeshi Morimoto; Koh Ono; Satoshi Shizuta; Yutaka Furukawa; Kazushige Kadota; Masashi Iwabuchi; Yoshihiro Kato; Satoru Suwa; Tsukasa Inada; Osamu Doi; Akinori Takizawa; Masakiyo Nobuyoshi; Toru Kita; Takeshi Kimura;
Related Documents :
10952794 - Complications and cost associated with parenteral nutrition delivered to hospitalized p...
9255894 - Fungemia in cancer patients undergoing chemotherapy versus surgery: risk factors, etiol...
12685414 - Cervical ripening: how long can the foley catheter safely remain in the cervical canal?
16597634 - Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: resul...
23689954 - Exchange reamed nailing compared to augmentation compression plating leaving the insert...
21705564 - Risk factors for symptomatic deep-vein thrombosis in patients after total ankle replace...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-2-28
Journal Detail:
Title:  The American journal of cardiology     Volume:  -     ISSN:  1879-1913     ISO Abbreviation:  -     Publication Date:  2012 Feb 
Date Detail:
Created Date:  2012-3-2     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 Elsevier Inc. All rights reserved.
Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Acute Kidney Injury (AKI) and Risk of Readmissions in Patients With Heart Failure.
Next Document:  Compartment-specific expression of plasminogen activator inhibitor-1 correlates with severity/outcom...